It has originally been proposed that leukemic cells with the HSC-like immunophenotype CD34+CD19- exclusively contained LSCs in both high and standard risk B-ALL [38,39]. The gene discussed is CD34; the disease is precursor B-cell acute lymphoblastic leukemia.